TRC105 in Adults With Advanced/Metastatic Urothelial Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Urothelial Carcinoma
Related studies linked through entity extraction aliases.
Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy in Patients With High-Grade Upper Tract Urothelial Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I/II Trial of AEZS-108 in Urothelial Cancer Patients Who Failed Platinum-chemotherapy
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
First-line Everolimus +/- Paclitaxel for Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Prospective Multicentric Evaluation of a Bladder Preservation Strategy
- Status
- TERMINATED
- Phase
- PHASE2
Second-Line Docetaxel + ASA404 for Advanced Urothelial Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Trial of Adjuvant Sutent for Patients With High Risk Urothelial Carcinoma After Neoadjuvant Chemotherapy and Cystectomy
- Status
- TERMINATED
- Phase
- PHASE2
Aristolochic Acid-DNA Adduct in Urothelial Carcinoma in Taiwan
- Status
- UNKNOWN
- Phase
- N/A
Arsenic Methylation Enzymes, Cigarette Metabolites, DNA Repair Enzymes, Inflammatory Factors and Urothelial Carcinoma
- Status
- UNKNOWN
- Phase
- N/A
Phase II Trial of Gemcitabine, Carboplatin, and Bevacizumab in Chemotherapy Naive Patients With Advanced/Metastatic Urothelial Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Phase I Study of Vorinostat in Combination With Docetaxel in Patients With Advanced and Relapsed Solid Malignancies.
- Status
- TERMINATED
- Phase
- PHASE1
Study of Neoadjuvant Ipilimumab in Patients With Urothelial Carcinoma Undergoing Surgical Resection
- Status
- COMPLETED
- Phase
- PHASE1